The Global Rat Model Market is Estimated to reach $1.7 Billion by 2028, at a CAGR of 7.4%

Published Date: 24-Nov-2022

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Rat Model Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Rat Model Market size is expected to reach $1.7 billion by 2028, rising at a market growth of 7.4% CAGR during the forecast period.

The Embryonic Stem Cell & Microinjection market is exhibiting a CAGR of 7.8% during (2022 - 2028). The expansion of the recognition of CRISPR-Cas9 for the Nobel Prize in Chemistry in 2020 has changed biological research. This technology has been used to create several rat models for use in drug-related research. A number of knockout rat models have been produced utilizing this technology.

The Outbred market is leading the segment in the Global Rat Model Market by Type in 2021; thereby, achieving a market value of $444.4 million by 2028. The outbred rats more accurately resemble the genetic variability of humans, resulting in their extensive usage in preclinical research. This adds to the increased proportion of crossbred models. These outbred rats are morphologically stable to a certain extent and far less vulnerable to environmental fluctuations, making them ideal for simulating the genetic abnormalities that lead to illnesses.

The Cryopreservation market is showcasing a CAGR of 7.8% during (2022 - 2028). This service comprises the ultra-freezing of embryos, sperm, and even study strains of the rat, as well as the creation of a cost-effective plan for storing and backing up the necessary models for future use. These cryoservices also preserve the intended model from contamination, natural disasters, unintended accidents, and gene modification or drift in future generations.

The Toxicology market is generating high revenue in the Global Rat Model Market by Application in 2021; thereby, achieving a market value of $660.8 million by 2028. Continuous demand for medications and therapies prompted the government and major healthcare providers to increase their investments. This insatiable desire for novel pharmaceuticals and therapies pushes research initiatives to improve the health infrastructure.

The Pharmaceutical & Biotechnology Companies market is registering a CAGR of 7.6% during (2022 - 2028). The expanded use of the rat model in the research and development pipeline and the manufacturing of medications and vaccines for autoimmune illnesses and infectious diseases have increased income generation. In addition, prominent actors are entering into exclusive agreements and collaborations to promote the commercialization of breakthrough research methods.

The North America market dominated the Global Rat Model Market by Region in 2021; thereby, achieving a market value of $648.3 million by 2028. The Europe market is anticipated to grow at a CAGR of 6.7% during (2022 - 2028). Additionally, The Asia Pacific market would witness a CAGR of 8.5% during (2022 - 2028).

Full Report: https://www.kbvresearch.com/rat-model-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Charles River Laboratories International, Inc., Laboratory Corporation of America Holdings, Inotiv, Inc., genOway, Janvier Labs, Taconic Biosciences, Inc. (H.I.G. Capital), TransViragen, Inc., Biomedical Research Models, Inc. (Biomere) and Cyagen Biosciences.

Global Rat Model Market Segmentation

By Technology

  • CRISPR/CAS & Others
  • Nuclear transferase
  • Embryonic Stem Cell & Microinjection

By Type

  • Outbred
  • Hybrid
  • Knockout
  • Inbred
  • Immunodeficient
  • Conditioned

By Service

  • Breeding
  • Genetic testing
  • Cryopreservation
  • Re-derivation
  • Quarantine Depending & Others

By Application

  • Toxicology
  • Oncology
  • Immunology
  • Neurology & Others

By End-use

  • CROs
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Charles River Laboratories International, Inc.
  • Laboratory Corporation of America Holdings
  • Inotiv, Inc.
  • genOway
  • Janvier Labs
  • Taconic Biosciences, Inc. (H.I.G. Capital)
  • TransViragen, Inc.
  • Biomedical Research Models, Inc. (Biomere)
  • Cyagen Biosciences

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

North America Rat Model Market size & Opportunities 2022-2028

Europe Rat Model Market & Growth Forecast 2022-2028

Asia Pacific Rat Model Market Share & Industry Outlook to 2028

LAMEA Rat Model Market Growth, Trends & Forecasts 2022-2028

Request a Free Sample Copy


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.